Dynamic soluble changes in sVEGFR1, HGF, and VEGF promote chemotherapy and bevacizumab resistance: A prospective translational study in the BECOX (GEMCAD 09-01) trial.
about
Dynamic soluble changes in sVEGFR1, HGF, and VEGF promote chemotherapy and bevacizumab resistance: A prospective translational study in the BECOX (GEMCAD 09-01) trial.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Dynamic soluble changes in sVE ...... he BECOX (GEMCAD 09-01) trial.
@en
type
label
Dynamic soluble changes in sVE ...... he BECOX (GEMCAD 09-01) trial.
@en
prefLabel
Dynamic soluble changes in sVE ...... he BECOX (GEMCAD 09-01) trial.
@en
P2093
P2860
P356
P1433
P1476
Dynamic soluble changes in sVE ...... the BECOX (GEMCAD 09-01) trial
@en
P2093
Beatriz Llorente
E Vila-Navarro
Estela Pineda
J Aparicio
M Gironella
P2860
P304
1010428317705509
P356
10.1177/1010428317705509
P577
2017-06-01T00:00:00Z